MYB and colorectal cancer: The upregulation of c-Myb in our inducible model is approximately 1.5- to 2-fold in vitro, depending on the cell line, which corresponds to dysregulated expression observed in patients with acute lymphoblastic leukemia or colorectal cancer (33, 34).